Common Contracts
255 similar Collaboration Agreement contracts by SGX Pharmaceuticals, Inc., Anadys Pharmaceuticals Inc, Regeneron Pharmaceuticals Inc, others
Exhibit 10.8 Collaboration Agreement Section 1: General Intention China Netcom of GuangXi Province ("Party A") and Beijing Candidsoft Technology Co. Ltd. ("Party B"), in accordance with People's Republic of China's Agreement Law and other regulations...Collaboration Agreement • August 6th, 2008 • China Voice Holding Corp.
Standard Contracts
BY AND AMONGCollaboration Agreement • December 15th, 2006 • MetaMorphix Inc. • Pharmaceutical preparations • Maryland
EXHIBIT 10.24 THIS AGREEMENT made in duplicate as of the 22 day of March, 2006, BETWEEN: MDS NORDION, a division of MDS (Canada) Inc. a corporation incorporated under the laws of Canada having a place of business at 447 March Road, Kanata, Ontario,...Collaboration Agreement • December 8th, 2006 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations • Ontario
RECITALSCollaboration Agreement • October 11th, 2006 • Neah Power Systems, Inc. • Miscellaneous electrical machinery, equipment & supplies • California
EX-10.23 AMENDED AND RESTATED COLLABORATION AGREEMENTCollaboration Agreement • October 3rd, 2006 • MetaMorphix Inc. • Pharmaceutical preparations • Maryland
RECITALSCollaboration Agreement • July 27th, 2006 • Neah Power Systems, Inc. • Miscellaneous electrical machinery, equipment & supplies • California
EXHIBIT 10.52 CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISKS DENOTE OMISSIONS. COLLABORATION AGREEMENTCollaboration Agreement • March 16th, 2006 • Osi Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • New York
Exhibit 10.10 COLLABORATION AGREEMENT (SUMMARY TRANSLATION) PARTY A: Shenzhen GrenTech Co., Ltd. PARTY B: Southeast University of China SECTION I PROJECT NAME Research and application of broadband wireless network technology (the "TECHNOLOGY")....Collaboration Agreement • March 13th, 2006 • China GrenTech CORP LTD
INTRODUCTIONCollaboration Agreement • February 28th, 2006 • Regeneron Pharmaceuticals Inc • Pharmaceutical preparations • New York
INTRODUCTIONCollaboration Agreement • February 28th, 2006 • Regeneron Pharmaceuticals Inc • Pharmaceutical preparations • New York
AGREEMENTCollaboration Agreement • January 18th, 2006 • Omrix Biopharmaceuticals, Inc.
Exhibit 10.1 Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request. Omissions are designated as **. A complete version of this exhibit has been...Collaboration Agreement • December 22nd, 2005 • Adolor Corp • Pharmaceutical preparations • Delaware
BACKGROUNDCollaboration Agreement • November 14th, 2005 • SGX Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
AMENDMENT NO. 1 TO THE COLLABORATION AGREEMENTCollaboration Agreement • November 14th, 2005 • Viacell Inc • Services-commercial physical & biological research • New York
BACKGROUNDCollaboration Agreement • November 14th, 2005 • SGX Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
BACKGROUNDCollaboration Agreement • November 14th, 2005 • SGX Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
BACKGROUNDCollaboration Agreement • September 2nd, 2005 • SGX Pharmaceuticals, Inc. • Delaware
BACKGROUNDCollaboration Agreement • September 2nd, 2005 • SGX Pharmaceuticals, Inc. • Delaware
BACKGROUNDCollaboration Agreement • September 2nd, 2005 • SGX Pharmaceuticals, Inc. • Delaware
ANDCollaboration Agreement • May 16th, 2005 • Alnylam Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
INTRODUCTIONCollaboration Agreement • March 11th, 2005 • Regeneron Pharmaceuticals Inc • Pharmaceutical preparations • New York
Exhibit 10.18 Portions redacted * Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.Collaboration Agreement • March 2nd, 2005 • Dragon Pharmaceutical Inc • Pharmaceutical preparations • British Columbia
Exhibit 10.2 - Collaboration Agreement COLLABORATION AGREEMENT THIS COLLABORATION AGREEMENT is made and entered as of July, 2004 by and between: (1) ACTIVEPOINT LTD., a company incorporated under the laws of the State of Israel, Co. no. 51-255867-7,...Collaboration Agreement • December 21st, 2004 • WWAP, Inc
RECITALSCollaboration Agreement • November 12th, 2004 • Anadys Pharmaceuticals Inc • Pharmaceutical preparations • California
AGREEMENTCollaboration Agreement • November 12th, 2004 • Anadys Pharmaceuticals Inc • Pharmaceutical preparations • New Jersey
ARTICLE 1 DEFINITIONSCollaboration Agreement • October 21st, 2004 • Cancervax Corp • Biological products, (no disgnostic substances) • California
EXHIBIT 10.1 COLLABORATION AGREEMENT This Agreement is made by and between Istituto Superiore di Sanita, Roma, Viale Regina Elena 299, Roma 00161, ITALY ("ISS") and GenoMed, Inc., 909 S. Taylor Ave., St. Louis, MO 63110, U.S.A. ("GenoMed"), effective...Collaboration Agreement • October 6th, 2004 • Genomed Inc • Pharmaceutical preparations
EXHIBIT 4.4Collaboration Agreement • September 24th, 2004 • Ym Biosciences Inc • Pharmaceutical preparations • Manitoba
COLLABORATION AGREEMENTCollaboration Agreement • July 26th, 2004 • Stereotaxis, Inc. • Electromedical & electrotherapeutic apparatus
AGREEMENTCollaboration Agreement • July 6th, 2004 • Idenix Pharmaceuticals Inc • Pharmaceutical preparations • New York
EXHIBIT 4.4Collaboration Agreement • May 18th, 2004 • Ym Biosciences Inc • Manitoba
COLLABORATION AGREEMENTCollaboration Agreement • May 12th, 2004 • Stereotaxis, Inc. • Electromedical & electrotherapeutic apparatus
EXHIBIT 10.48 SECOND AMENDMENT OF THE COLLABORATION AGREEMENT This Second Amendment (this "SECOND AMENDMENT") to the Collaboration Agreement is made and entered into as of October 7, 2003, by and between EPIMMUNE INC., having a principal place of...Collaboration Agreement • May 10th, 2004 • Epimmune Inc • Pharmaceutical preparations
EXHIBIT 10.50Collaboration Agreement • May 10th, 2004 • Epimmune Inc • Pharmaceutical preparations • California
AMENDMENT NO. 1 TO THE AGREEMENT DATED AUGUST 7, 2002 BETWEEN HOFFMAN-LA ROCHE, INC. AND ANADYS PHARMACEUTICALS, INC.Collaboration Agreement • March 18th, 2004 • Anadys Pharmaceuticals Inc • Pharmaceutical preparations
